Author

Carly Dillen

University of Maryland, Baltimore

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

Matthew B. FriemaniD· 3 shared Achsah Dorsey KeeganiD· 1 shared Alexander N.R. WeberiD· 1 shared Alireza Rahimi· 1 shared Amal Gebara-LambiD· 1 shared Andrea A. GustiD· 1 shared Anil K. Sen GuptaiD· 1 shared Anshul Chaudhary· 1 shared

Activity by Year

2018-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Matthew B. FriemanORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990

N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva, Malina A. Bakowski, Simeon Babarinde, Anshul Chaudhary, Mark Zeller, Ashley K. Woods, Gennadii A. Grabovyi, Katy B. Wilson, Rebecca A. Leonard, Briana Lynn McGovern, Jared Benjamin, Isidora D. Suazo, Mary Gordon, , Arnab K. Chatterjee

This study evaluates CMX990, a coronavirus Mpro inhibitor, showing broad antiviral activity against multiple coronaviruses and superior pharmacologic properties compared to existing inhibitors.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology

Allergic airway inflammation protects against SARS-CoV-2 and MERS-CoV disease but promotes fatal SARS-CoV-1 immunopathology

Jeremy Ardanuy, Grace Garrett, Carly Dillen, Meizi Liu, Louis J. Taylor, Achsah Dorsey Keegan, Michael S. Diamond, Matthew B. Frieman

bioRxiv · Sep 7, 2026 · PreprintMicrobiology

Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvant

Devon V Riley, Lauren Baracco, Sayan Das, Brandon M Tenaglia, Sydney Speed, Carly Dillen, Juliahna Hayes, Samanta Del Veliz, Haye Nijhuis, Valerie Le Sage, Hannah W. Despres, Lynda Coughlan, Weina Sun, Matthew B. Frieman, Robert K. Ernst

This study evaluates a novel TLR4 adjuvant, BECC470s, in enhancing rHA vaccination against H5N1 influenza in mice, showing improved antibody responses but limited cross-neutralizing activity.

mSphere · Jul 10, 2026Peer-reviewedImmunology

The fungal ligand chitin directly binds and signals inflammation dependent on oligomer size and TLR2

Katharina Fuchs, Yamel Cardona Gloria, Olaf-Oliver Wolz, Franziska Herster, Lokesh Sharma, Carly Dillen, Christoph Täumer, Sabine Dickhöfer, Zsofia Bittner, Truong-Minh Dang, Anurag Singh, Daniel Haischer, Maria A. Schlöffel, Kirsten J. Koymans, Tharmila Sanmuganantham, , Alexander N.R. Weber

This study identifies chitin oligomers as the smallest immunologically active motif and TLR2 as the primary receptor for chitin, showing size-dependent signaling and therapeutic potential.

bioRxiv · Mar 5, 2018 · PreprintImmunology